Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.790
+0.070 (4.07%)
Aug 21, 2025, 10:23 AM - Market open

Immuron Revenue

Immuron had revenue of 3.99M AUD in the half year ending December 31, 2024, with 584.38% growth. This brings the company's revenue in the last twelve months to 6.54M, up 82.90% year-over-year. In the fiscal year ending June 30, 2024, Immuron had annual revenue of 4.90M with 171.67% growth.

Revenue (ttm)
6.54M AUD
Revenue Growth
+82.90%
P/S Ratio
3.07
Revenue / Employee
934,518 AUD
Employees
7
Market Cap
12.43M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.37M-94.21%
Jun 30, 20202.52M131.14K5.49%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings